In-vitro Diagnostic Services Market Size By Service Type {Software (Standalone Software, Software Update), Testing Services (Infectious Testing, Diabetes Testing, Molecular Testing, Tissue Testing)}, By End-user (Hospitals, Point-Of-Care Testing, Laboratories, Academic Institutes), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, UK, Italy, Spain, Russia, China, Japan, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa, UAE), Application Potential, Competitive Market Share & Forecast, 2018 – 2024

Published Date: September 2018 | 185 Pages | Report ID: GMI2889 Report Format: PDF

  Request Sample Inquiry Before Buying
Summary Table of Contents Industry Coverage Methodology Request for Customization

Industry Trends

In-vitro Diagnostic Services market size was valued at USD 44.0 billion in 2017 and is expected to witness 5.4% CAGR from 2018 to 2024.
 

U.S. In-vitro Diagnostic Services Market, By Software, 2013 – 2024 (USD Billion)
U.S. In-vitro Diagnostic Services Market, By Software, 2013 – 2024 (USD Billion)

 

Rising number of cancer cases in Asian as well as western countries should drive in-vitro diagnostic services industry growth in upcoming years. According to Livemint in 2016, India had over 3.9 million cases of cancer that will accelerate the demand for in-vitro diagnostic services. Moreover, growing elderly population suffering from chronic diseases such as diabetes and cardiovascular disorders will influence the industry growth. In the U.S., there are around 78 million people in the age group of 65 years and above. Majority of elderly people suffer from at least one chronic disease or infection that should upsurge the demand for in-vitro diagnostic services in near future.
 

Increasing rate of detection of genetic and infectious diseases in developed economies will escalate in-vitro diagnostic services market growth. Over 133 million Americans are detected with at least one chronic disease that will increase the demand for in-vitro diagnostic services surging industry growth. American organizations such as National Association of Chronic Diseases implements certain initiatives that will raise awareness of disease detection among the population should positively influence in-vitro diagnostic services industry growth. However, high costs associated with diagnostic services will restrain industry growth.
 

In-vitro Diagnostic Services Market, By Service Type

Software segment will grow at 4.5% over the forecast timeframe due to growing preference for reliable and efficient diagnostic software that will help to maintain patient’s record. Also, software enables analysis of the gene sequencing information that will boost drug discovery process and is expected to render positive impact on segmental growth. In-vitro diagnostic companies such as Roche have partnered with Microsoft and Cleidon that will help in broadening its software offerings and will also prove beneficial for business growth.
 

Testing services segment was valued at USD 34.8 billion in 2017 and is projected to grow significantly over the forecast timeframe as a result of growing elderly population globally will augment demand for in-vitro diagnostic services surging the segmental growth. High demand for diagnostic services such as mammography, colonoscopy, blood tests and liquid biopsy should further augment the industry growth. According to CDC in 2015, 65.3% women in the age group of 40 years and above underwent the mammography tests in the U.S. that should impel segmental growth in forthcoming years.
 

In-vitro Diagnostic Services Market, By End-user

Hospital segment of in-vitro diagnostic services market will grow at 4.3% over the forecast timeframe due to increasing prevalence of chronic diseases in developed as well as developing countries. Moreover, growing healthcare associated infections should impact the segmental growth positively. According to CDC in 2015, Americans spent around 32.3% of the total expenditures on hospital care that will enhance business growth.
 

Point-of-care testing segment accounted for 23.5% revenue share in 2017 and is expected to grow over the forecast timeframe. Technological advancements coupled with increasing prevalence of genetic diseases requiring critical monitoring should increase demand for point-of-care testing that will upsurge the segment growth in forthcoming years.
 

In-vitro Diagnostic Services Market, By Region

U.S. dominated North America in-vitro diagnostic services market and was valued at USD 16.7 billion in 2017 as a result of increasing demand for diagnostic services and growing adoption rate of software. Development in public healthcare system will increase the availability of superior quality diagnostic services that should impel industry growth in upcoming years.
 

Germany in-vitro diagnostic services market will grow at 4.5% CAGR over the estimated forecast timeframe. Exponential regional growth can be attributed to increasing adoption rate of superior quality diagnostic devices that enhances the performance of diagnostic procedures stimulating the industry growth in future. Moreover, increasing geriatric population preferring in-vitro diagnostic services will trigger the industry growth.
 

Competitive Market Share

Major industry players include BioRad, DexCom, Nova Biomedical, OraSure, Pearl Pathways, Phenomenex, Qiagen, Roche diagnostics, Siemens, Sysmex and Thermofisher. These industry players adopt strategic initiatives that help them to maintain their market share. For instance, Roche developed Accu-check 3600 diabetes management software that ensures accurate storage of patient’s information and helps in reviewing the historical data. Addition of new products to the portfolio will enhance revenue generation for the company.
 

In-vitro Diagnostic Services Industry Background
 

In-vitro Diagnostic Services Market

In-vitro diagnostic services market is consolidated in nature and is dominated by only few industry players. Additionally, in-vitro diagnostic services industry has evolved drastically and has led to improvements in the software developed by the companies. For instance, organizations such as Roche diagnostics and OraSure are merging with leading software companies to enhance their product offerings to sustain market competition. Also, with an increase in prevalence of cancer globally, the key industry players have added innovations in most preferred diagnostic tests such as mammography, echocardiography and colonoscopy that facilitates efficient diagnosis thereby, escalating demand for diagnostic services in forthcoming years. Furthermore, development in vendor and overall distribution network of the suppliers for software utilised under in-vitro diagnostic services will ensure sustainable industry growth.
 


What Information does this report contain?

Historical data coverage: 2013 to 2017; Growth Projections: 2018 to 2024.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.


Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability

Why Global Market Insights?

 Comprehensive Research
  • All-inclusive coverage
  • In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
  • Penetrative insights & latest trends
  • Offers holistic understanding of the market
 Data Accuracy & Reliability
  • Unique methodology
  • Iterative in nature to eliminate errors
  • Detailed methodology, scope, assumptions and data sources available for reference
 Post-Sales Support
  • Committed to making a positive difference for our clients
  • Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
  • Every purchase comes with an option to obtain additional information:
    • up to 10% of the original cost
    • 45-minute analyst tele-call to obtain further clarity on the market.
 Security & Confidentiality
  • Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
  • Only PCI-DSS compliant payment methods used for highest level of client data security
This site is protected by Trustwave's Trusted Commerce program Authorize.Net Merchant - Click to Verify

Connect with our sales team